Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
212M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
74M
-
Shares change
-
-3.54M
-
Total reported value, excl. options
-
$471M
-
Value change
-
-$44.1M
-
Put/Call ratio
-
0.8
-
Number of buys
-
84
-
Number of sells
-
-74
-
Price
-
$6.37
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2020
220 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2020.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74M shares
of 212M outstanding shares and own 34.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.38M shares), VANGUARD GROUP INC (8.55M shares), WASATCH ADVISORS INC (5.94M shares), STATE STREET CORP (4.85M shares), Bellevue Group AG (3.85M shares), CREDIT SUISSE AG/ (2.76M shares), EcoR1 Capital, LLC (2.31M shares), DIMENSIONAL FUND ADVISORS LP (2.2M shares), TANG CAPITAL MANAGEMENT LLC (2.03M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.69M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.